Metastatic Tumor: Clinical Trials

4 trials for Metastatic Tumor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed, 1 recruiting, 1 terminated. 4 Phase 2, 2 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Active not recruiting 1, Completed 1, Recruiting 1, Terminated 1
Phase 12Active not recruiting 1, Terminated 1
Phase 31Completed 1

Follow Metastatic Tumor: new trials by email Literature Review of Metastatic Tumor trials Research Report on Metastatic Tumor

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Definitive Radiation for High-Risk Spine Metastases
SBRT to the spine - Metastatic Cancer, Metastatic Lung Cancer
Phase 2RecruitingStony Brook University262023-12-142025-05-14
Study Evaluating the Benefit of Adding Ipilimumab to the Combination of Atezolizumab and Bevacizumab in Patients With Hepatocellular Carcinoma Receiving First-line Systemic Therapy
Ipilimumab Injection, Atezolizumab Injection, Bevacizumab - HCC - Hepatocellular Carcinoma, Metastatic Cancer
Phase 2 / Phase 3CompletedFederation Francophone de Cancerologie Digestive2292023-03-092026-03-09
A First-in-Human, Phase 1 Study of TST003 in Subjects With Solid Tumors
TST003 - Locally Advanced Solid Tumor, Metastatic Tumor
Phase 1 / Phase 2Active not recruitingTranscenta Therapeutics (Hangzhou) Co., Ltd.1112023-02-082026-09-29
Safety, Tolerability, and Anti-Tumor Activity of AFM24 in Combination With SNK01 in Subjects With Advanced/Metastatic EGFR-Expressing Cancers
AFM24, SNK01 - Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung
Phase 1 / Phase 2TerminatedNKGen Biotech, Inc.112021-11-032024-03-01

Narrower conditions

Neoplasm Metastasis (4)  ·  Lung Neoplasms (2)  ·  Bone Neoplasms (1)  ·  Breast Neoplasms (1)  ·  Carcinoma, Hepatocellular (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Colorectal Neoplasms (1)  ·  Neoplasms (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)

Broader conditions

Neoplastic Processes (4)  ·  Pathologic Processes (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Neoplasms (3)  ·  Neoplasms by Site (3)  ·  Carcinoma (2)  ·  Digestive System Diseases (2)  ·  Digestive System Neoplasms (2)  ·  Lung Diseases (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms, Glandular and Epithelial (2)  ·  Respiratory Tract Diseases (2)  ·  Respiratory Tract Neoplasms (2)  ·  Thoracic Neoplasms (2)  ·  Adenocarcinoma (1)

Interventions

Bevacizumab (1)  ·  Ipilimumab (1)  ·  atezolizumab (1)

Sponsors

Federation Francophone de Cancerologie Digestive (1)  ·  NKGen Biotech, Inc. (1)  ·  Stony Brook University (1)  ·  Transcenta Therapeutics (Hangzhou) Co., Ltd. (1)

Countries

United States (3)  ·  France (1)

Top investigators

Kartik Mani, MD PhD (1)  ·  Paul Chang, MPH (1)

Results publications

PMID 42330996